Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 231

1.

Management and treatment of uncomplicated imported malaria in adults. Update of the French malaria clinical guidelines.

Epelboin L, Rapp C, Faucher JF, Méchaï F, Bottieau E, Matheron S, Malvy D, Caumes E.

Med Mal Infect. 2019 Sep 4. pii: S0399-077X(18)30708-X. doi: 10.1016/j.medmal.2019.07.011. [Epub ahead of print] No abstract available.

PMID:
31493957
2.

Limited HIV-2 reservoirs in central-memory CD4 T-cells associated to CXCR6 co-receptor expression in attenuated HIV-2 infection.

Samri A, Charpentier C, Diallo MS, Bertine M, Even S, Morin V, Oudin A, Parizot C, Collin G, Hosmalin A, Cheynier R, Thiébaut R, Matheron S, Collin F, Zoorob R, Brun-Vézinet F, Autran B; ANRS CO5 IMMUNOVIR-2 Study Group.

PLoS Pathog. 2019 May 16;15(5):e1007758. doi: 10.1371/journal.ppat.1007758. eCollection 2019 May.

3.

New insights are game-changers in HIV-2 disease management.

Le Hingrat Q, Charpentier C, Ghosn J, Thiébaut R, Peytavin G, Descamps D, Matheron S.

Lancet HIV. 2019 Apr;6(4):e214. doi: 10.1016/S2352-3018(19)30088-8. No abstract available.

PMID:
30942186
4.

The intestinal microbiota predisposes to traveler's diarrhea and to the carriage of multidrug-resistant Enterobacteriaceae after traveling to tropical regions.

Leo S, Lazarevic V, Gaïa N, Estellat C, Girard M, Matheron S, Armand-Lefèvre L, Andremont A The VOYAG-R study group, Schrenzel J, Ruppé E.

Gut Microbes. 2019;10(5):631-641. doi: 10.1080/19490976.2018.1564431. Epub 2019 Feb 3.

PMID:
30714464
5.

Acquisition of plasmid-mediated cephalosporinase producing Enterobacteriaceae after a travel to the tropics.

Lorme F, Maataoui N, Rondinaud E, Esposito-Farèse M, Clermont O, Ruppe E, Arlet G, Genel N; VOYAG-R study group, Matheron S, Andremont A, Armand-Lefevre L.

PLoS One. 2018 Dec 18;13(12):e0206909. doi: 10.1371/journal.pone.0206909. eCollection 2018.

6.

Practical generic guidelines for paediatric-to-adult transition for adolescents with chronic disease.

Le Roux E, Mellerio H, Jacquin P, Bourmaud A, Guilmin-Crépon S, Faye A, Matheron S, Boulkedid R, Alberti C.

Eur J Public Health. 2019 Jun 1;29(3):442-448. doi: 10.1093/eurpub/cky258.

PMID:
30535247
7.

Metabolic risk factors in young adults infected with HIV since childhood compared with the general population.

Arrive E, Viard JP, Salanave B, Dollfus C, Matheron S, Reliquet V, Arezes E, Nailler L, Vigouroux C, Warszawski J; ANRS CO19 COVERTE and ENNS study groups.

PLoS One. 2018 Nov 8;13(11):e0206745. doi: 10.1371/journal.pone.0206745. eCollection 2018.

8.

A new mechanism of resistance of HIV-2 to integrase inhibitors: a 5 amino-acids insertion in the integrase C-terminal domain.

Le Hingrat Q, Collin G, Lê M, Peytavin G, Visseaux B, Bertine M, Tubiana R, Karmochkine M, Valin N, Collin F, Lemaignen A, Bernard L, Damond F, Matheron S, Descamps D, Charpentier C; ANRS CO5 HIV-2 Cohort.

Clin Infect Dis. 2018 Nov 1. doi: 10.1093/cid/ciy940. [Epub ahead of print]

PMID:
30383215
9.

Influence of geographic origin on AIDS and serious non-AIDS morbidity/mortality during cART among heterosexual HIV-infected men and women in France.

de Monteynard LA, Matheron S, Grabar S, de Truchis P, Gilquin J, Pavie J, Launay O, Meynard JL, Khuong-Josses MA, Rey D, Mahamat A, Dray-Spira R, Simon A, Costagliola D, Abgrall S; FHDH-ANRS CO4.

PLoS One. 2018 Oct 31;13(10):e0205385. doi: 10.1371/journal.pone.0205385. eCollection 2018.

10.

B7-H6-mediated downregulation of NKp30 in natural killer cells contributes to HIV-2 immune escape.

Lucar O, Sadjo Diallo M, Bayard C, Samri A, Tarantino N, Debré P, Thiébaut R, Brun-Vézinet F, Matheron S, Cheynier R, Vieillard V; ANRS CO5 IMMUNOVIR-2 Study group.

AIDS. 2019 Jan 27;33(1):23-32. doi: 10.1097/QAD.0000000000002061.

PMID:
30325780
11.

Immunogenicity and safety of yellow fever vaccine in HIV-1-infected patients.

Colin de Verdiere N, Durier C, Samri A, Meiffredy V, Launay O, Matheron S, Mercier-Delarue S, Even S, Aboulker JP, Molina JM, Autran B, Simon F; ANRS EP46 NOVAA Group.

AIDS. 2018 Oct 23;32(16):2291-2299. doi: 10.1097/QAD.0000000000001963.

PMID:
30096071
12.

First-line Raltegravir/Emtricitabine/Tenofovir Combination in Human Immunodeficiency Virus Type 2 (HIV-2) Infection: A Phase 2, Noncomparative Trial (ANRS 159 HIV-2).

Matheron S, Descamps D, Gallien S, Besseghir A, Sellier P, Blum L, Mortier E, Charpentier C, Tubiana R, Damond F, Peytavin G, Ponscarme D, Collin F, Brun-Vezinet F, Chene G; France REcherche Nord&Sud Sida-Hiv Hépatites (ANRS) 159 HIV-2 Trial Study Group .

Clin Infect Dis. 2018 Sep 28;67(8):1161-1167. doi: 10.1093/cid/ciy245.

13.

Efficiency of HIV-2 cultures from clinical isolates is enhanced after purification by anti-CD44 microbeads.

Le Hingrat Q, Perrier M, Collin G, Drumard S, Storto A, Bertine M, Larrouy L, Matheron S, Damond F, Charpentier C, Descamps D, Visseaux B.

J Virol Methods. 2018 Jul;257:12-15. doi: 10.1016/j.jviromet.2018.03.010. Epub 2018 Mar 26.

PMID:
29588254
14.

Minority resistant variants are also present in HIV-2-infected antiretroviral-naive patients.

Storto A, Visseaux B, Bertine M, Le Hingrat Q, Collin G, Damond F, Khuong MA, Blum L, Tubiana R, Karmochkine M, Cazanave C, Matheron S, Descamps D, Charpentier C; ANRS HIV-2 CO5 Cohort.

J Antimicrob Chemother. 2018 May 1;73(5):1173-1176. doi: 10.1093/jac/dkx530.

PMID:
29415189
15.

Corrigendum to "HIV-2 molecular epidemiology" [Infect. Genet. Evol. 46 (2016) 233-240].

Visseaux B, Damond F, Matheron S, Descamps D, Charpentier C.

Infect Genet Evol. 2018 Mar;58:294. doi: 10.1016/j.meegid.2017.12.024. Epub 2018 Jan 5. No abstract available.

PMID:
29307762
16.

HBV or HCV Coinfection in HIV-1-Infected Pregnant Women in France: Prevalence and Pregnancy Outcomes.

Benhammou V, Tubiana R, Matheron S, Sellier P, Mandelbrot L, Chenadec JL, Marel E, Khoshnood B, Warszawski J; ANRS CO1/CO11-EPF French Perinatal Cohort study group.

J Acquir Immune Defic Syndr. 2018 Apr 15;77(5):439-450. doi: 10.1097/QAI.0000000000001618.

PMID:
29287028
17.

Correction to: Imported falciparum malaria in adults: host- and parasite-related factors associated with severity. The French prospective multicenter PALUREA cohort study.

Bruneel F, Tubach F, Mira JP, Houze S, Gibot S, Huisse MG, Megarbane B, Choquet C, Corne P, Peytel E, Villers D, Camus C, Bouchaud O, Caumes E, Girard PM, Simon F, Kalloumeh A, Roy C, Durand R, Le Bras J, Matheron S, Wolff M; PALUREA Study Group.

Intensive Care Med. 2018 Jan;44(1):141-143. doi: 10.1007/s00134-017-4978-7.

PMID:
29138897
18.

CD4 cell count response to first-line combination ART in HIV-2+ patients compared with HIV-1+ patients: a multinational, multicohort European study.

Wittkop L, Arsandaux J, Trevino A, Schim van der Loeff M, Anderson J, van Sighem A, Böni J, Brun-Vezinet F, Soriano V, Boufassa F, Brockmeyer N, Calmy A, Dabis F, Jarrin I, Dorrucci M, Duque V, Fätkenheuer G, Zangerle R, Ferrer E, Porter K, Judd A, Sipsas NV, Lambotte O, Shepherd L, Leport C, Morrison C, Mussini C, Obel N, Ruelle J, Schwarze-Zander C, Sonnerborg A, Teira R, Torti C, Valadas E, Colin C, Friis-Møller N, Costagliola D, Thiebaut R, Chene G, Matheron S; COHERE in EuroCoord and ACHIeV2e Study Group.

J Antimicrob Chemother. 2017 Oct 1;72(10):2869-2878. doi: 10.1093/jac/dkx210.

19.

No evidence for major adverse events related to suspicion of Ebola in France, 2014-2015.

Lachâtre M, Méchain M, Etienne M, Gautret P, Matheron S, Nahon M, Coignard-Biehler H, Malvy D, Duval X, Tattevin P.

Clin Microbiol Infect. 2018 Mar;24(3):310-311. doi: 10.1016/j.cmi.2017.09.004. Epub 2017 Sep 9. No abstract available.

20.

New Highly Sensitive Real-Time PCR Assay for HIV-2 Group A and Group B DNA Quantification.

Bertine M, Gueudin M, Mélard A, Damond F, Descamps D, Matheron S, Collin F, Rouzioux C, Plantier JC, Avettand-Fenoel V.

J Clin Microbiol. 2017 Sep;55(9):2850-2857. doi: 10.1128/JCM.00755-17. Epub 2017 Jul 12.

21.

Zika virus infection: report of the first imported cases in a Paris travel centre.

Sokal A, D'Ortenzio E, Houhou-Fidouh N, Brichler S, Dorchies J, Cabras O, Leparc-Goffart I, Yazdanpanah Y, Matheron S.

J Travel Med. 2016 Jul 1;24(1). doi: 10.1093/jtm/taw066.

PMID:
28679155
22.

Cyclophilins and nucleoporins are required for infection mediated by capsids from circulating HIV-2 primary isolates.

Mamede JI, Damond F, Bernardo A, Matheron S, Descamps D, Battini JL, Sitbon M, Courgnaud V.

Sci Rep. 2017 Mar 27;7:45214. doi: 10.1038/srep45214.

23.

Switch as maintenance to elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate: week 48 results in a clinical cohort.

Perrier M, Charpentier C, Peytavin G, Lê M, Blondel L, Visseaux B, Joly V, Pinto A, Matheron S, Yazdanpanah Y, Descamps D, Landman R.

J Antimicrob Chemother. 2017 Jun 1;72(6):1745-1751. doi: 10.1093/jac/dkx018.

PMID:
28186251
24.

Preservation of Lymphopoietic Potential and Virus Suppressive Capacity by CD8+ T Cells in HIV-2-Infected Controllers.

Angin M, Wong G, Papagno L, Versmisse P, David A, Bayard C, Charmeteau-De Muylder B, Besseghir A, Thiébaut R, Boufassa F, Pancino G, Sauce D, Lambotte O, Brun-Vézinet F, Matheron S, Rowland-Jones SL, Cheynier R, Sáez-Cirión A, Appay V; ANRS CO5 IMMUNOVIR-2 Study Group.

J Immunol. 2016 Oct 1;197(7):2787-95. doi: 10.4049/jimmunol.1600693. Epub 2016 Aug 26.

25.

Hiv-2 molecular epidemiology.

Visseaux B, Damond F, Matheron S, Descamps D, Charpentier C.

Infect Genet Evol. 2016 Dec;46:233-240. doi: 10.1016/j.meegid.2016.08.010. Epub 2016 Aug 12. Review. Erratum in: Infect Genet Evol. 2018 Jan 4;:.

PMID:
27530215
26.

Long-Lasting Persistence of Zika Virus in Semen.

Matheron S, d'Ortenzio E, Leparc-Goffart I, Hubert B, de Lamballerie X, Yazdanpanah Y.

Clin Infect Dis. 2016 Nov 1;63(9):1264. Epub 2016 Jul 28. No abstract available.

PMID:
27470244
27.

Influence of geographic origin, sex, and HIV transmission group on the outcome of first-line combined antiretroviral therapy in France.

de Monteynard LA, Matheron S, Gilquin J, Pavie J, de Truchis P, Grabar S, Launay O, Meynard JL, Khuong-Josses MA, Rey D, Simon A, Mahamat A, Dray-Spira R, Costagliola D, Abgrall S; FHDH-ANRS CO4.

AIDS. 2016 Sep 10;30(14):2235-46. doi: 10.1097/QAD.0000000000001193.

PMID:
27428741
28.

Imported falciparum malaria in adults: host- and parasite-related factors associated with severity. The French prospective multicenter PALUREA cohort study.

Bruneel F, Tubach F, Mira JP, Houze S, Gibot S, Huisse MG, Megarbane B, Choquet C, Corne P, Peytel E, Villers D, Camus C, Bouchaud O, Caumes E, Girard PM, Simon F, Kalloumeh A, Roy C, Durand R, Le Bras J, Matheron S, Wolff M; PALUREA Study Group.

Intensive Care Med. 2016 Oct;42(10):1588-1596. doi: 10.1007/s00134-016-4356-x. Epub 2016 May 11. Erratum in: Intensive Care Med. 2017 Nov 14;:.

PMID:
27169586
29.

[Zika virus infection during pregnancy].

Picone O, Vauloup-Fellous C, D'Ortenzio E, Huissoud C, Carles G, Benachi A, Faye A, Luton D, Paty MC, Ayoubi JM, Yazdanpanah Y, Mandelbrot L, Matheron S.

J Gynecol Obstet Biol Reprod (Paris). 2016 May;45(5):415-23. doi: 10.1016/j.jgyn.2016.03.005. Epub 2016 Apr 11. Review. French.

30.

Evidence of Sexual Transmission of Zika Virus.

D'Ortenzio E, Matheron S, Yazdanpanah Y, de Lamballerie X, Hubert B, Piorkowski G, Maquart M, Descamps D, Damond F, Leparc-Goffart I.

N Engl J Med. 2016 Jun 2;374(22):2195-8. doi: 10.1056/NEJMc1604449. Epub 2016 Apr 13. No abstract available.

31.

Women infected with human immunodeficiency virus type 1 have poorer assisted reproduction outcomes: a case-control study.

Stora C, Epelboin S, Devouche E, Matheron S, Epelboin L, Yazbeck C, Damond F, Longuet P, Dzineku F, Rajguru M, Delaroche L, Mandelbrot L, Luton D, Patrat C.

Fertil Steril. 2016 May;105(5):1193-1201. doi: 10.1016/j.fertnstert.2015.12.138. Epub 2016 Jan 19.

PMID:
26801068
32.

Short article: Hepatitis B virus status in children born to HIV/HBV coinfected women in a French hospital: a cross-sectional study.

Sellier PO, Schnepf N, Amarsy R, Maylin S, Lopes A, Mazeron MC, Flateau C, Morgand M, Ciraru-Vigneron N, Berthe A, Simoneau G, Evans J, Souak S, Matheron S, Benifla JL, Simon F, Bergmann JF.

Eur J Gastroenterol Hepatol. 2016 Mar;28(3):328-32. doi: 10.1097/MEG.0000000000000559.

PMID:
26709883
33.

HIV-2 Vif Diversity Among Defective and Nondefective Sequences.

Bertine M, Visseaux B, Storto A, Collin G, Matheron S, Descamps D, Charpentier C; ANRS CO5 HIV-2 Cohort.

J Acquir Immune Defic Syndr. 2016 May 1;72(1):e9-e11. doi: 10.1097/QAI.0000000000000924. No abstract available.

PMID:
26689972
34.

Foscarnet, zidovudine and dolutegravir combination efficacy and tolerability for late stage HIV salvage therapy: A case-series experience.

Delory T, Papot E, Rioux C, Charpentier C, Auge-Courtoi C, Michard F, Peytavin G, Descamps D, Matheron S, Yazdanpanah Y.

J Med Virol. 2016 Jul;88(7):1204-10. doi: 10.1002/jmv.24442. Epub 2016 Jan 5.

PMID:
26636432
35.

Tropism distribution among antiretroviral-naive HIV-2-infected patients.

Visseaux B, Charpentier C, Ozanne A, Nizard A, Drumard S, Fagard C, Glohi D, Damond F, Brun-Vézinet F, Matheron S, Descamps D; ANRS CO5 HIV-2 Cohort.

AIDS. 2015 Oct 23;29(16):2209-12. doi: 10.1097/QAD.0000000000000825.

PMID:
26544584
36.

Reply to Collignon and Kennedy.

Ruppé E, Armand-Lefèvre L, Estellat C, Coignard B, Lucet JC, Andremont A, Matheron S.

Clin Infect Dis. 2015 Dec 1;61(11):1767. doi: 10.1093/cid/civ705. Epub 2015 Aug 13. No abstract available.

PMID:
26276883
37.

Cenicriviroc, a Novel CCR5 (R5) and CCR2 Antagonist, Shows In Vitro Activity against R5 Tropic HIV-2 Clinical Isolates.

Visseaux B, Charpentier C, Collin G, Bertine M, Peytavin G, Damond F, Matheron S, Lefebvre E, Brun-Vézinet F, Descamps D; ANRS CO5 HIV-2 Cohort.

PLoS One. 2015 Aug 6;10(8):e0134904. doi: 10.1371/journal.pone.0134904. eCollection 2015.

38.

No perinatal HIV-1 transmission from women with effective antiretroviral therapy starting before conception.

Mandelbrot L, Tubiana R, Le Chenadec J, Dollfus C, Faye A, Pannier E, Matheron S, Khuong MA, Garrait V, Reliquet V, Devidas A, Berrebi A, Allisy C, Elleau C, Arvieux C, Rouzioux C, Warszawski J, Blanche S; ANRS-EPF Study Group.

Clin Infect Dis. 2015 Dec 1;61(11):1715-25. doi: 10.1093/cid/civ578. Epub 2015 Jul 21.

PMID:
26197844
39.

High level of APOBEC3F/3G editing in HIV-2 DNA vif and pol sequences from antiretroviral-naive patients.

Bertine M, Charpentier C, Visseaux B, Storto A, Collin G, Larrouy L, Damond F, Matheron S, Brun-Vézinet F, Descamps D; ANRS CO5 HIV-2 Cohort.

AIDS. 2015 Apr 24;29(7):779-84. doi: 10.1097/QAD.0000000000000607.

PMID:
25985400
40.

HIV-serodiscordant couples desiring a child: 'treatment as prevention,' preexposure prophylaxis, or medically assisted procreation?

Mabileau G, Schwarzinger M, Flores J, Patrat C, Luton D, Epelboin S, Mandelbrot L, Matheron S, Yazdanpanah Y.

Am J Obstet Gynecol. 2015 Sep;213(3):341.e1-12. doi: 10.1016/j.ajog.2015.05.010. Epub 2015 May 13.

PMID:
25979615
41.

High Rate of Acquisition but Short Duration of Carriage of Multidrug-Resistant Enterobacteriaceae After Travel to the Tropics.

Ruppé E, Armand-Lefèvre L, Estellat C, Consigny PH, El Mniai A, Boussadia Y, Goujon C, Ralaimazava P, Campa P, Girard PM, Wyplosz B, Vittecoq D, Bouchaud O, Le Loup G, Pialoux G, Perrier M, Wieder I, Moussa N, Esposito-Farèse M, Hoffmann I, Coignard B, Lucet JC, Andremont A, Matheron S.

Clin Infect Dis. 2015 Aug 15;61(4):593-600. doi: 10.1093/cid/civ333. Epub 2015 Apr 22.

PMID:
25904368
42.

Delayed-onset hemolytic anemia in patients with travel-associated severe malaria treated with artesunate, France, 2011-2013.

Jauréguiberry S, Thellier M, Ndour PA, Ader F, Roussel C, Sonneville R, Mayaux J, Matheron S, Angoulvant A, Wyplosz B, Rapp C, Pistone T, Lebrun-Vignes B, Kendjo E, Danis M, Houzé S, Bricaire F, Mazier D, Buffet P, Caumes E; French Artesunate Working Group.

Emerg Infect Dis. 2015 May;21(5):804-12. doi: 10.3201/eid2105.141171.

43.

Vasculoplacental complications in pregnant women with HIV infection: a case-control study.

Canlorbe G, Matheron S, Mandelbrot L, Oudet B, Luton D, Azria E.

Am J Obstet Gynecol. 2015 Aug;213(2):241.e1-9. doi: 10.1016/j.ajog.2015.03.035. Epub 2015 Mar 19.

PMID:
25797234
44.

Later cART initiation in migrant men from sub-Saharan Africa without advanced HIV disease in France.

de Monteynard LA, Dray-Spira R, de Truchis P, Grabar S, Launay O, Meynard JL, Khuong-Josses MA, Gilquin J, Rey D, Simon A, Pavie J, Mahamat A, Matheron S, Costagliola D, Abgrall S; French Hospital Database on HIV.

PLoS One. 2015 Mar 3;10(3):e0118492. doi: 10.1371/journal.pone.0118492. eCollection 2015.

45.

Dolutegravir in HIV-2-Infected Patients With Resistant Virus to First-line Integrase Inhibitors From the French Named Patient Program.

Descamps D, Peytavin G, Visseaux B, Tubiana R, Damond F, Campa P, Charpentier C, Khuong-Josses MA, Duvivier C, Karmochkine M, Lukiana T, Matheron S.

Clin Infect Dis. 2015 May 15;60(10):1521-7. doi: 10.1093/cid/civ124. Epub 2015 Feb 17.

PMID:
25690598
46.

Pharmacokinetics, safety and efficacy of ritonavir-boosted atazanavir (300/100 mg once daily) in HIV-1-infected pregnant women.

Lê MP, Mandelbrot L, Descamps D, Soulié C, Ichou H, Bourgeois-Moine A, Damond F, Lariven S, Valantin MA, Landman R, Faucher P, Tubiana R, Duro D, Meier F, Legac S, Bourse P, Mortier E, Dommergues M, Calvez V, Matheron S, Peytavin G.

Antivir Ther. 2015;20(5):507-13. doi: 10.3851/IMP2936. Epub 2015 Jan 20.

PMID:
25599649
47.

[Which future for HIV-infected children at adolescence and adulthood? ].

Matheron S, Girard T.

Rev Prat. 2014 Oct;64(8):1091-3. French. No abstract available.

PMID:
25510132
48.

Ebola: should we consider influenza vaccination?

Matheron S, Baize S, Lerat I, Houhou N, Yazdanpanah Y.

Lancet. 2014 Dec 6;384(9959):2023-4. doi: 10.1016/S0140-6736(14)62226-1. Epub 2014 Nov 19. No abstract available.

PMID:
25467571
49.

Effectiveness and cost of quick diagnostic tests to determine tetanus immunity in patients with a wound in French emergency departments.

N'Diaye DS, Schwarzinger M, Obach D, Poissy J, Matheron S, Casalino E, Yazdanpanah Y.

BMC Infect Dis. 2014 Nov 19;14:603. doi: 10.1186/s12879-014-0603-3.

50.

Hepatitis B virus (HBV) status of children born to HIV/HBV co-infected women in a French hospital: a cross-sectional study.

Sellier P, Schnepf N, Amarsy R, Maylin S, Coutellier M, Lopes A, Mazeron MC, Flateau C, Morgand M, Ciraru-Vigneron N, Berthe A, Ricbourg A, Dolores-Moreno AM, Simoneau G, Evans J, Souak S, Matheron S, Mouly S, Benifla JL, Simon F, Bergmann JF.

J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19632. doi: 10.7448/IAS.17.4.19632. eCollection 2014.

Supplemental Content

Loading ...
Support Center